MeiraGTx to Present at Barclays Gene Editing & Gene Therapy Summit

Tuesday, November 28, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK and LONDON, Nov. 28, 2017 /PRNewswire/ -- MeiraGTx, a New York and London

based gene therapy company, today announced that Alexandria Forbes, Ph.D., President and Chief Executive Officer, will present an overview of the company and its clinical programs at the Barclays Gene Editing & Gene
Therapy Summit on Thursday November 30th, 2017 at 11:20 a.m. at the Barclays offices in New York City.

About MeiraGTx  MeiraGTx is committed to the development of novel gene therapies to transform the lives of patients suffering from acquired and inherited disorders.  The company is developing treatments for ocular diseases, including rare inherited blindness and age-related macular degeneration (AMD).  MeiraGTx is also establishing treatments for xerostomia, a frequent and debilitating side effect of radiation treatment used in head and neck cancers, as well as certain neurodegenerative diseases.  In addition, MeiraGTx is developing novel gene regulation platforms that promise to transform the way gene therapy can be applied and create new paradigms for biologic therapeutics.

Contact:Andy MerrillProsek Partners212-279-3115, ext. 216

View original content:http://www.prnewswire.com/news-releases/meiragtx-to-present-at-barclays-gene-editing--gene-therapy-summit-300562308.html

SOURCE MeiraGTx



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store